EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Inflammatory Nexus of Bronchopulmonary Dysplasia: From Molecular Pathways to Precision Therapeutics

Fei Wang iD, Heng Zhang iD, Ou Jiang iD, Hongying Mi iD

Mediators of Inflammation · 2026

DOI: 10.1155/mi/9480568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, 2026. Verfasst von Fei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan Province, China, ypfph.com. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kunming University of Science and Technology, Hospital Research Fund of Yunnan First People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchopulmonary dysplasia (BPD) is a common and serious complication among preterm infants, particularly those born at extremely low gestational ages. It is primarily characterized by impaired alveolar and vascular development. Inflammation is increasingly recognized as a central mechanism in its pathogenesis. Both prenatal factors, such as intrauterine infection, and postnatal insults, including mechanical ventilation, oxygen toxicity, and infection, can trigger and sustain a dysregulated inflammatory response in the immature lung. This response involves the activation of inflammatory cells, such as neutrophils and macrophages, and the release of pro‐inflammatory mediators, reactive oxygen species (ROS), and proteases. These factors disrupt critical developmental signaling pathways and contribute to alveolar simplification and abnormal vascular growth, which are the hallmark features of BPD. Current therapeutic strategies aim to limit these inflammatory processes and support lung development. Established interventions like caffeine and corticosteroids have demonstrated varying levels of effectiveness and safety. Emerging therapies—including anti‐cytokine agents, inflammasome inhibitors, and stem cell‐based approaches—offer promising avenues by specifically targeting the inflammatory cascade. Additionally, supportive strategies such as non‐invasive ventilation, careful oxygen titration, and optimal nutrition play essential roles in reducing initial injury and facilitating recovery. Inflammation is a key mediator linking diverse perinatal insults to the disrupted lung development seen in BPD. A deeper understanding of the inflammatory mechanisms and timely, targeted interventions may offer improved outcomes for this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaInflammationHumansAnimalsReactive Oxygen SpeciesInfant, NewbornSignal TransductionInfant, Premature

Stichwörter der Autor:innen

alveolar simplificationanti-inflammatory therapybronchopulmonary dysplasiacytokinesinflammationlung developmentmesenchymal stem cell therapyoxidative stresspremature infantsvascular dysregulation

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan Province, China, ypfph.com.
  • School of Medicine, Kunming University of Science and Technology, 68 Wenchang Road, Kunming, 650093, Yunnan Province, China, kmust.edu.cn.
  • Department of Neonatology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China, ypfph.com.

ORCID-Profile: Fei Wang, Heng Zhang, Ou Jiang, Hongying Mi

Förderung

  • Kunming University of Science and Technology
  • Hospital Research Fund of Yunnan First People's Hospital

Zitieren

APA

Wang, F., Zhang, H., Jiang, O., & Mi, H. (2026). The Inflammatory Nexus of Bronchopulmonary Dysplasia: From Molecular Pathways to Precision Therapeutics. Mediators of Inflammation. https://doi.org/10.1155/mi/9480568

Vancouver

Wang F, Zhang H, Jiang O, Mi H. The Inflammatory Nexus of Bronchopulmonary Dysplasia: From Molecular Pathways to Precision Therapeutics. Mediators of Inflammation. 2026. doi:10.1155/mi/9480568

BibTeX
@article{Wang2026,
  author = {Wang, Fei and Zhang, Heng and Jiang, Ou and Mi, Hongying},
  title = {The Inflammatory Nexus of Bronchopulmonary Dysplasia: From Molecular Pathways to Precision Therapeutics},
  journal = {Mediators of Inflammation},
  year = {2026},
  doi = {10.1155/mi/9480568}
}
Kostenlos starten →